Jul 21, 2026Added BI 3034701 (Boehringer Ingelheim / Gubra), the first GLP-1/GIP/NPY2 triple agonist to reach Phase 2 with no efficacy data public yet
Uncommon (1-10 in 1000 people): gallbladder problems, pancreatitis, allergic reactions, dizziness
Nie ma potrzeby stosowania BPC-157 wycznie wieczorem
Systemic inflammation that is characteristic of obesity and diabetes can, over time, damage tissues in the body, and accelerate the degeneration of joints and development of osteoarthritis
Adherence and Persistence Medication non-adherence is higher in obesity patients compared to diabetes patients
Melanotan-II (MT2) 10mg $50.00 Volume discounts Auto-applied at checkout Free shipping on orders of $200+ Compound Identity COMPOUND NAME Melanotan-2 SYNONYMS Melanotan-II, MT-II CAS NUMBER 121062-08-6 MOLECULAR FORMULA C 50 H 69 N 15 O 9 MOLECULAR WEIGHT ~1024.2 g/mol STRUCTURE Cyclic heptapeptide analog PEPTIDE SEQUENCE Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH
)
